Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "Nivo + Low Dose Ipi as 1L Therapy in Advanced GC or GEJ MSI-H Tumor - First Results of the NO LIMIT Study"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Kei Muro
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Kei Muro
Login to view comments.
Click here to Login
Gastrointestinal